Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion description "[The cancer antigen CA 15-3 has been used as a possible serum marker of occult and recurrent breast carcinoma, either alone or in combination with other tumor markers such as HER2/neu, that has evolved as a major classifier of invasive breast cancer and target of therapy for the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion evidence source_evidence_literature NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion SIO_000772 24674678 NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion wasDerivedFrom befree-2016 NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion wasGeneratedBy ECO_0000203 NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.